Pediatric high-grade glioma: moving toward subtype-specific multimodal therapy
- PMID: 33523591
- DOI: 10.1111/febs.15739
Pediatric high-grade glioma: moving toward subtype-specific multimodal therapy
Abstract
Pediatric high-grade gliomas (pHGG) comprise a deadly, heterogenous category of pediatric gliomas with a clear need for more effective treatment options. Advances in high-throughput molecular techniques have enhanced molecular understanding of these tumors, but outcomes are still poor, and treatments beyond resection and radiation have not yet been clearly established as standard of care. In this review, we first discuss the history of treatment approaches to pHGG to this point. We then review four distinct categories of pHGG, including histone 3-mutant, IDH-mutant, histone 3/IDH-wildtype, and radiation-induced pHGG. We discuss the molecular understanding of each subgroup and targeted treatment options in development. Finally, we look at the development and current status of two novel approaches to pHGG as a whole: localized convection-enhanced chemotherapy delivery and immunotherapy, including checkpoint inhibitors, vaccine therapy, and CAR-T cells. Through this review, we demonstrate the potential for rational, molecularly driven, subtype-specific therapy to be used with other novel approaches in combinations that could meaningfully improve the prognosis in pHGG.
Keywords: convection-enhanced delivery; immunotherapy; pediatric high-grade glioma; radiation-induced glioma.
© 2021 Federation of European Biochemical Societies.
Similar articles
-
Molecular Genetics and Targeted Therapies for Paediatric High-grade Glioma.Cancer Genomics Proteomics. 2022 Jul-Aug;19(4):390-414. doi: 10.21873/cgp.20328. Cancer Genomics Proteomics. 2022. PMID: 35732328 Free PMC article. Review.
-
Hemispherical Pediatric High-Grade Glioma: Molecular Basis and Therapeutic Opportunities.Int J Mol Sci. 2020 Dec 17;21(24):9654. doi: 10.3390/ijms21249654. Int J Mol Sci. 2020. PMID: 33348922 Free PMC article. Review.
-
Impact of the H3K27M mutation on survival in pediatric high-grade glioma: a systematic review and meta-analysis.J Neurosurg Pediatr. 2018 Nov 30;23(3):308-316. doi: 10.3171/2018.9.PEDS18419. J Neurosurg Pediatr. 2018. PMID: 30544362
-
Cutting Edge Therapeutic Insights Derived from Molecular Biology of Pediatric High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG).Bioengineering (Basel). 2018 Oct 18;5(4):88. doi: 10.3390/bioengineering5040088. Bioengineering (Basel). 2018. PMID: 30340362 Free PMC article. Review.
-
Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.J Neurosurg Pediatr. 2017 May;19(5):518-530. doi: 10.3171/2016.9.PEDS16152. Epub 2017 Feb 17. J Neurosurg Pediatr. 2017. PMID: 28291423
Cited by
-
New CNS tumor classification: The importance in pediatric neurosurgical practice.Surg Neurol Int. 2024 Apr 12;15:130. doi: 10.25259/SNI_681_2023. eCollection 2024. Surg Neurol Int. 2024. PMID: 38742003 Free PMC article. Review.
-
Prevalence and risk factors of early postoperative seizures in patients with glioma: A protocol for meta-analysis and systematic review.PLoS One. 2024 Apr 4;19(4):e0301443. doi: 10.1371/journal.pone.0301443. eCollection 2024. PLoS One. 2024. PMID: 38574171 Free PMC article.
-
Novel insights on genetics and epigenetics as clinical targets for paediatric astrocytoma.Clin Transl Med. 2024 Feb;14(2):e1560. doi: 10.1002/ctm2.1560. Clin Transl Med. 2024. PMID: 38299304 Free PMC article. Review.
-
Predicting the WHO Grading of Pediatric Brain Tumors Based on Their MRI Appearance: A Retrospective Study.Cureus. 2023 Oct 19;15(10):e47333. doi: 10.7759/cureus.47333. eCollection 2023 Oct. Cureus. 2023. PMID: 38021610 Free PMC article.
-
Chemotherapy in pediatric brain tumor and the challenge of the blood-brain barrier.Cancer Med. 2023 Dec;12(23):21075-21096. doi: 10.1002/cam4.6647. Epub 2023 Nov 23. Cancer Med. 2023. PMID: 37997517 Free PMC article. Review.
References
-
- Ostrom QT, de Blank PM, Kruchko C, Petersen CM, Liao P, Finlay JL, Stearns DS, Wolff JE, Wolinsky Y, Letterio JJ et al. (2015) Alex's lemonade stand foundation infant and childhood primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro Oncol 16 (Suppl 10), x1-x36.
-
- Finlay JL, Boyett JM, Yates AJ, Wisoff JH, Milstein JM, Geyer JR, Bertolone SJ, McGuire P, Cherlow JM & Tefft M (1995) Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. J Clin Oncol 13, 112-123.
-
- Sposto R, Ertel IJ, Jenkin RD, Boesel CP, Venes JL, Ortega JA, Evans AE, Wara W & Hammond D (1989) The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. J Neurooncol 7, 165-177.
-
- Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K et al. (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10, 459-466.
-
- Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB & Herman JG (2000) Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343, 1350-1354.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical